Stem Cells http://www.epitomics.com
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasui, K.
Right arrow Articles by Nakano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasui, K.
Right arrow Articles by Nakano, T.

Stem Cells 2003;21:143-151 www.StemCells.com
© 2003 AlphaMed Press

Differences Between Peripheral Blood and Cord Blood in the Kinetics of Lineage-Restricted Hematopoietic Cells: Implications for Delayed Platelet Recovery Following Cord Blood Transplantation

Kazuta Yasui, Kayoko Matsumoto, Fumiya Hirayama, Yoshihiko Tani, Toru Nakano

Osaka Red Cross Blood Center, Osaka, Japan; Department of Molecular Cell Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

Key Words. AC133 antigen • CD34 antigen • Cord blood • Peripheral blood

Kayoko Matsumoto, Ph.D., Osaka Red Cross Blood Center, Morinomiya 2-4-43, Johtoh-ku, Osaka 536-8505, Japan. Telephone: 81-6-6962-7056; Fax: 81-6-6962-7652; e-mail: kayokoma{at}a1.mbn.or.jp

Cord blood (CB) cells are a useful source of hematopoietic cells for transplantation. The hematopoietic activities of CB cells are different from those of bone marrow and peripheral blood (PB) cells. Platelet recovery is significantly slower after transplantation with CB cells than with cells from other sources. However, the cellular mechanisms underlying these differences have not been elucidated. We compared the surface marker expression profiles of PB and CB hematopoietic cells. We focused on two surface markers of hematopoietic cell immaturity, i.e., CD34 and AC133. In addition to differences in surface marker expression, the PB and CB cells showed nonidentical differentiation pathways from AC133+CD34+ (immature) hematopoietic cells to terminally differentiated cells. The majority of the AC133+CD34+ PB cells initially lost AC133 expression and eventually became AC133-CD34- cells. In contrast, the AC133+CD34+ CB cells did not go through the intermediate AC133-CD34+ stage and lost both markers simultaneously. Meanwhile, the vast majority of megakaryocyte progenitors were of the AC133-CD34+ phenotype. We conclude that the delayed recovery of platelets after CB transplantation is due to both subpopulation distribution and the process of differentiation from AC133+CD34+ cells.




This article has been cited by other articles:


Home page
Stem CellsHome page
E. Goussetis, M. Theodosaki, G. Paterakis, C. Tsecoura, and S. Graphakos
In Vitro Identification of a Cord Blood CD133+CD34-Lin+ Cell Subset that Gives Rise to Myeloid Dendritic Precursors
Stem Cells, April 1, 2006; 24(4): 1137 - 1140.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2003 by AlphaMed Press.